{'fraction_non_alphanumeric': 0.025780189959294438, 'fraction_numerical': 0.018995929443690638, 'mean_word_length': 5.15, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[The use of blood phosphatidylinositol indices for the diagnosis of tumorous diseases of the maxillofacial area].

Phosphatidyl inositol levels were measured by flow thin-layer chromatography in red cells, platelets, lymphocytes, plasma, and whole blood of 198 patients with maxillofacial malignant and benign tumors and in 50 donors. Phosphatidyl inositol levels in the blood and its fragments were found reduced twofold in the patients with malignant tumors as against controls. Reduction of blood phosphatidyl inositol level to 185 +/- 11.0 mol of phosphatidyl inositol phosphorus per liter evidences the presence of a malignant tumor in the maxillofacial area in 97.6% of cases, this being confirmed by x-ray and histologic findings.